Presenilin 1 Interacts with Acetylcholinesterase and Alters Its Enzymatic Activity and Glycosylation

REFERENCES

• Aldudo, J., M. J. Bullido, A. Frank, and F. Valdivieso. 1998. Missense mutation E318G of the presenilin-1 gene appears to be a nonpathogenic polymorphism. Ann. Neurol. 44:985–986.
   PubMedGoogle Scholar
• Annaert, W. G., L. Levesque, K. Craessaerts, I. Dierinck, G. Snellings, and D. Westaway. 1999. Presenilin 1 controls γ-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons. J. Cell Biol. 147:277–294.
   PubMed Web of Science ®Google Scholar
• Borchelt, D. R., G. Thinakaran, C. B. Eckman, M. K. Lee, F. Davenport, T. Ratovitsky, C. M. Prada, G. Kim, S. Seekins, D. Yager, H. H. Slunt, R. Wang, M. Seeger, A. I. Levey, S. E. Gandy, N. G. Copeland, N. A. Jenkins, D. L. Price, S. G. Younkin, and S. S. Sisodia. 1996. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17:1005–1013.
   PubMed Web of Science ®Google Scholar
• Bourne, Y., P. Taylor, Z. Radic, and P. Marchot. 2003. Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site. EMBO J. 22:1–12.
   PubMed Web of Science ®Google Scholar
• Braak, H., and E. Braak. 1998. Evolution of neuronal changes in the course of Alzheimer's disease. J. Neural Transm. Suppl. 53:127–140.
   PubMedGoogle Scholar
• Campion, D., J. M. Flaman, A. Brice, D. Hannequin, B. Dubois, C. Martin, V. Moreau, F. Charbonnier, O. Didierjean, S. Tardieu, C. Penet, M. Puel, F. Pasquier, F. Le Doze, G. Bellis, A. Calenda, R. Heilig, M. Martinez, J. Mallet, M. Bellis, F. Clerget-Darpoux, Y. Agid, and T. Frebourg. 1995. Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum. Mol. Genet. 4:2373–2377.
   PubMed Web of Science ®Google Scholar
• Capell, A., J. Grünberg, B. Pesold, A. Diehlmann, M. Citron, R. Nixon, K. Beyreuther, D. J. Selkoe, and C. Haass. 1998. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. J. Biol. Chem. 273:3205–3211.
   PubMed Web of Science ®Google Scholar
• Chatel, J. M., J. Grassi, Y. Frobert, J. Massoulié, and F. M. Vallette. 1993. Existence of an inactive pool of acetylcholinesterase in chicken brain. Proc. Natl. Acad. Sci. USA 90:2476–2480.
   PubMedGoogle Scholar
• Chen, F., D. S. Yang, S. Petanceska, A. Yang, A. Tandon, G. Yu, R. Rozmahel, J. Ghiso, M. Nishimura, D. M. Zhang, T. Kawarai, G. Levesque, J. Mills, L. Levesque, Y. Q. Song, E. Rogaeva, D. Westaway, H. Mount, S. Gandy, P. St George-Hyslop, and P. E. Fraser. 2000. Carboxyl-terminal fragments of Alzheimer beta-amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cells. J. Biol. Chem. 275:36794–36802.
   PubMed Web of Science ®Google Scholar
• Chevallier, N. L., S. Soriano, D. E. Kang, E. Masliah, G. Hu, and E. H. Koo. 2005. Perturbed neurogenesis in the adult hippocampus associated with presenilin-1 A246E mutation. Am. J. Pathol. 167:151–159.
   PubMed Web of Science ®Google Scholar
• Culvenor, J. G., F. Maher, G. Evin, F. Malchiodi-Albedi, R. Cappai, J. R. Underwood, J. B. Davis, E. H. Karran, G. W. Roberts, K. Beyreuther, and C. L. Masters. 1997. Alzheimer's disease-associated presenilin 1 in neuronal cells: evidence for localization to the endoplasmic reticulum-Golgi intermediate compartment. J. Neurosci. Res. 49:719–731.
   PubMed Web of Science ®Google Scholar
• Darreh-Shori, T., E. Hellstrom-Lindahl, C. Flores-Flores, Z. Z. Guan, H. Soreq, and A. Nordberg. 2004. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients. J. Neurochem. 88:1102–1113.
   PubMed Web of Science ®Google Scholar
• Davies, P., and A. J. Maloney. 1976. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet i:1403.
   Google Scholar
• Diehlmann, A., N. Ida, S. Weggen, J. Grunberg, C. Haass, C. L. Masters, T. A. Bayer, and K. Beyreuther. 1999. Analysis of presenilin 1 and presenilin 2 expression and processing by newly developed monoclonal antibodies. J. Neurosci. Res. 56:405–419.
   PubMedGoogle Scholar
• Efthimiopoulos, S., D. Vassilacopoulou, J. A. Ripellino, N. Tezapsidis, and N. K. Robakis. 1996. Cholinergic agonists stimulate secretion of soluble full-length amyloid precursor protein in neuroendocrine cells. Proc. Natl. Acad. Sci. USA 93:8046–8050.
   PubMedGoogle Scholar
• Evin, G., R. A. Sharples, A. Weidemann, F. B. Reinhard, V. Carbone, J. G. Culvenor, R. M. Holsinger, M. F. Sernee, K. Beyreuther, and C. L. Masters. 2001. Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimer's disease. Biochemistry 40:8359–8368.
   PubMedGoogle Scholar
• Farquhar, M. J., C. W. Gray, and K. C. Breen. 2003. The overexpression of the wild-type or mutant forms of the presenilin-1 protein alters glycoprotein processing in a human neuroblastoma cell line. Neurosci. Lett. 346:53–56.
   PubMedGoogle Scholar
• Fishman, E. B., G. C. Siek, R. D. MacCallum, E. D. Bird, L. Volicer, and J. K. Marquis. 1986. Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type. Ann. Neurol. 19:246–252.
   PubMed Web of Science ®Google Scholar
• Gandy, S. J. 2005. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J. Clin. Investig. 115:1121–1129.
   PubMed Web of Science ®Google Scholar
• García-Ayllón, M. S., M. X. Silveyra, A. Candela, A. Compañ, J. Clària, R. Jover, M. Pérez-Mateo, V. Felipo, S. Martínez, J. Galcerán, and J. Sáez-Valero. 2006. Changes in liver and plasma acetylcholinesterase in rats with cirrhosis induced by bile duct ligation. Hepatology 43:444–453.
   PubMedGoogle Scholar
• García-Ayllón, M. S., M. X. Silveyra, N. Andreasen, S. Brimijoin, K. Blennow, and J. Sáez-Valero. 2007. Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease. J. Neurochem. 101:1701–1711.
   PubMed Web of Science ®Google Scholar
• Geula, C., and M. Mesulam. 1989. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. Brain Res. 498:185–189.
   PubMedGoogle Scholar
• Hashimoto, Y., E. Tsukamoto, T. Niikura, Y. Yamagishi, M. Ishizaka, S. Aiso, A. Takashima, and I. Nishimoto. 2004. Amino- and carboxyl-terminal mutants of presenilin 1 cause neuronal cell death through distinct toxic mechanisms: study of 27 different presenilin 1 mutants. J. Neurosci. Res. 75:417–428.
   PubMed Web of Science ®Google Scholar
• Hébert, S. S., V. Bourdages, C. Godin, M. Ferland, M. Carreau, and G. Lévesque. 2003. Presenilin-1 interacts directly with the beta-site amyloid protein precursor cleaving enzyme (BACE1). Neurobiol. Dis. 13:238–245.
   PubMedGoogle Scholar
• Hu, W., N. W. Gray, and S. Brimijoin. 2003. Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation. J. Neurochem. 86:470–478.
   PubMedGoogle Scholar
• Huynh, D. P., H. V. Vinters, D. H. Ho, V. V. Ho, and S. M. Pulst. 1997. Neuronal expression and intracellular localization of presenilins in normal and Alzheimer disease brains. J. Neuropathol. Exp. Neurol. 56:1009–1017.
   PubMedGoogle Scholar
• Inestrosa, N. C., A. Alvarez, C. A. Pérez, R. D. Moreno, M. Vicente, C. Linker, O. I. Casanueva, C. Soto, and J. Garrido. 1996. Acetylcholinestearse accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16:881–891.
   PubMed Web of Science ®Google Scholar
• Kaether, C., S. Lammich, D. Edbauer, M. Ertl, J. Rietdorf, A. Capell, H. Steiner, and C. Haass. 2002. Presenilin-1 affects trafficking and processing of βAPP and is targeted in a complex with nicastrin to the plasma membrane. J. Cell Biol. 158:551–561.
   PubMed Web of Science ®Google Scholar
• Kaufer, D., A. Friedman, S. Seidman, and H. Soreq. 1998. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393:373–377.
   PubMed Web of Science ®Google Scholar
• Kim, T. W., W. H. Pettingell, Y. K. Jung, D. M. Kovacs, and R. E. Tanzi. 1997. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277:373–376.
   PubMed Web of Science ®Google Scholar
• Kovacs, D. M., H. J. Fausett, K. J. Page, T. W. Kim, R. D. Moir, D. E. Merriam, R. D. Hollister, O. G. Hallmark, R. Mancini, K. M. Felsenstein, B. T. Hyman, R. E. Tanzi, and W. Wasco. 1996. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2:224–229.
   PubMed Web of Science ®Google Scholar
• Lahiri, D. K., S. Lewis, and M. R. Farlow. 1994. Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines. J. Neurosci. Res. 37:777–787.
   PubMed Web of Science ®Google Scholar
• Lalonde, R., S. Qian, and C. Strazielle. 2003. Transgenic mice expressing the PS1-A246E mutation: effects on spatial learning, exploration, anxiety, and motor coordination. Behav. Brain Res. 138:71–79.
   PubMedGoogle Scholar
• Lee, M. K., H. H. Slunt, L. J. Martin, G. Thinakaran, G. Kim, S. E. Gandy, M. Seeger, E. Koo, D. L. Price, and S. S. Sisodia. 1996. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J. Neurosci. 16:7513–7525.
   PubMedGoogle Scholar
• Leem, J. Y., C. A. Saura, C. Pietrzik, J. Christianson, C. Wanamaker, L. T. King, M. L. Veselits, T. Tomita, L. Gasparini, T. Iwatsubo, H. Xu, W. N. Green, E. H. Koo, and G. Thinakaran. 2002. A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface. Neurobiol. Dis. 11:64–82.
   PubMed Web of Science ®Google Scholar
• Leem, J. Y., S. Vijayan, P. Han, D. Cai, M. Machura, K. O. Lopes, M. L. Veselits, H. Xu, and G. Thinakaran. 2002. Presenilin 1 is required for maturation and cell surface accumulation of nicastrin. J. Biol. Chem. 277:19236–19240.
   PubMed Web of Science ®Google Scholar
• Levey, A. I., C. J. Heilman, J. J. Lah, N. R. Nash, H. D. Rees, M. Wakai, S. S. Mirra, D. B. Rye, D. Nochlin, T. D. Bird, and E. J. Mufson. 1997. Presenilin-1 protein expression in familial and sporadic Alzheimer's disease. Ann. Neurol. 41:742–753.
   PubMedGoogle Scholar
• Loetscher, H., U. Deuschle, M. Brockhaus, D. Reinhardt, P. Nelboeck, J. Mous, J. Grünberg, C. Haass, and H. Jacobsen. 1997. Presenilins are processed by caspase-type proteases. J. Biol. Chem. 272:20655–20659.
   PubMedGoogle Scholar
• Massoulié, J. 2002. The origin of the molecular diversity and functional anchoring of cholinesterases. Neurosignals 11:130–143.
   PubMedGoogle Scholar
• Mathews, P. M., A. M. Cataldo, B. H. Kao, A. G. Rudnicki, X. Qin, J. L. Yang, Y. Jiang, M. Picciano, C. Hulette, C. F. Lippa, T. D. Bird, D. Nochlin, J. Walter, C. Haass, L. Lévesque, P. E. Fraser, A. Andreadis, and R. A. Nixon. 2000. Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease. Mol. Med. 6:878–891.
   PubMedGoogle Scholar
• Mattila, K. M., C. Forsell, T. Pirttilä, J. O. Rinne, T. Lehtimäki, M. Röyttä, L. Lilius, A. Eerola, P. H. St George-Hyslop, H. Frey, and L. Lannfelt. 1998. The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease. Ann. Neurol. 44:965–967.
   PubMedGoogle Scholar
• Morán, M. A., E. J. Mufson, and P. Gómez-Ramos. 1994. Cholinesterases colocalize with sites of neurofibrillary degeneration in aged and Alzheimer's brains. Acta Neuropathol. 87:284–292.
   PubMedGoogle Scholar
• Mori, F., C. C. Lai, F. Fusi, and E. Giacobini. 1995. Cholinesterase inhibitors increase secretion of APPs in rat brain cortex. Neuroreport 6:633–636.
   PubMed Web of Science ®Google Scholar
• Murayama, O., T. Tomita, N. Nihonmatsu, M. Murayama, X. Sun, T. Honda, T. Iwatsubo, and A. Takashima. 1999. Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease. Neurosci. Lett. 265:61–63.
   PubMed Web of Science ®Google Scholar
• Naruse, S., G. Thinakaran, J. J. Luo, J. W. Kusiak, T. Tomita, T. Iwatsubo, X. Qian, D. D. Ginty, D. L. Price, D. R. Borchelt, P. C. Wong, and S. S. Sisodia. 1998. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21:1213–1221.
   PubMed Web of Science ®Google Scholar
• Nguyen, H. N., D. Y. Hwang, Y. K. Kim, D. Y. Yoon, J. H. Kim, M. S. Lee, M. K. Lee, Y. P. Yun, K. W. Oh, and J. T. Hong. 2005. Mutant presenilin 2 increases acetylcholinesterase activity in neuronal cells. Arch. Pharm. Res. 28:1073–1078.
   PubMedGoogle Scholar
• Nieto-Cerón, S., M. T. Moral-Naranjo, E. Muñoz-Delgado, C. J. Vidal, and F. J. Campoy. 2004. Molecular properties of acetylcholinesterase in mouse spleen. Neurochem. Int. 45:129–139.
   PubMedGoogle Scholar
• Nijholt, I., N. Farchi, M. Kye, E. H. Sklan, S. Shoham, B. Verbeure, D. Owen, B. Hochner, J. Spiess, H. Soreq, and T. Blank. 2004. Stress-induced alternative splicing of acetylcholinesterase results in enhanced fear memory and long-term potentiation. Mol. Psychiatry 9:174–183.
   PubMed Web of Science ®Google Scholar
• Nitsch, R. M., B. E. Slack, R. J. Wurtman, and J. H. Growdon. 1992. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258:304–307.
   PubMed Web of Science ®Google Scholar
• Parent, A., D. J. Linden, S. S. Sisodia, and D. R. Borchelt. 1999. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1. Neurobiol. Dis. 6:56–62.
   PubMed Web of Science ®Google Scholar
• Parks, A. L., and D. Curtis. 2007. Presenilin diversifies its portfolio. Trends Genet. 23:140–150.
   PubMed Web of Science ®Google Scholar
• Perrier, N. A., M. Salani, C. Falasca, S. Bon, G. Augusti-Tocco, and J. Massoulié. 2005. The readthrough variant of acetylcholinesterase remains very minor after heat shock, organophosphate inhibition and stress, in cell culture and in vivo. J. Neurochem. 94:629–638.
   PubMed Web of Science ®Google Scholar
• Perry, E. K., R. H. Perry, G. Blessed, and B. E. Tomlinson. 1977. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet i:189.
   Google Scholar
• Podlisny, M. B., M. Citron, P. Amarante, R. Sherrington, W. Xia, J. Zhang, T. Diehl, G. Levesque, P. Fraser, C. Haass, E. H. Koo, P. Seubert, P. St George-Hyslop, D. B. Teplow, and D. J. Selkoe. 1997. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol. Dis. 3:325–337.
   PubMed Web of Science ®Google Scholar
• Popescu, B. O., A. Cedazo-Minguez, E. Benedikz, T. Nishimura, B. Winblad, M. Ankarcrona, and R. F. Cowburn. 2004. Gamma-secretase activity of presenilin 1 regulates acetylcholine muscarinic receptor-mediated signal transduction. J. Biol. Chem. 279:6455–6464.
   PubMedGoogle Scholar
• Probst, A., D. Langui, and J. Ulrich. 1991. Alzheimer's disease: a description of the structural lesions. Brain Pathol. 1:229–239.
   PubMed Web of Science ®Google Scholar
• Puelles, E., D. Acampora, R. Gogoi, F. Tuorto, A. Papalia, F. Guillemot, S. L. Ang, and A. Simeone. 2006. Otx2 controls identity and fate of glutamatergic progenitors of the thalamus by repressing GABAergic differentiation. J. Neurosci. 26:5955–5964.
   PubMedGoogle Scholar
• Qian, S., P. Jiang, X. M. Guan, G. Singh, M. E. Trumbauer, H. Yu, H. Y. Chen, L. H. Van de Ploeg, and H. Zheng. 1998. Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Aβ1-42/43 expression. Neuron 20:611–617.
   PubMed Web of Science ®Google Scholar
• Queralt, R., M. Ezquerra, A. Lleó, M. Castellví, J. Gelpí, I. Ferrer, N. Acarín, L. Pasarín, R. Blesa, and R. Oliva. 2002. A novel mutation (V89L) in the presenilin 1 gene in a family with early onset Alzheimer's disease and marked behavioral disturbances. J. Neurol. Neurosurg. Psychiatry 72:266–269.
   PubMedGoogle Scholar
• Rees, T., P. I. Hammond, H. Soreq, S. Younkin, and S. Brimijoin. 2003. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol. Aging 24:777–787.
   PubMed Web of Science ®Google Scholar
• Rees, T. M., A. Berson, E. H. Sklan, L. Younkin, S. Younkin, S. Brimijoin, and H. Soreq. 2005. Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic mice. Curr. Alzheimer Res. 2:291–300.
   PubMedGoogle Scholar
• Robitzki, A., A. Mack, U. Hoppe, A. Chatonnet, and P. G. Layer. 1997. Regulation of cholinesterase gene expression affects neuronal differentiation as revealed by transfection studies on reaggregating embryonic chicken retinal cells. Eur. J. Neurosci. 9:2394–2405.
   PubMedGoogle Scholar
• Rossner, S., U. Ueberham, R. Schliebs, J. R. Pérez-Polo, and V. Bigl. 1998. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling. Prog. Neurobiol. 56:541–569.
   PubMed Web of Science ®Google Scholar
• Rotundo, R. L. 1988. Biogenesis of acetylcholinesterase molecular forms in muscle: evidence for a rapidly turning over, catalytically inactive precursor pool. J. Biol. Chem. 263:19398–19406.
   PubMed Web of Science ®Google Scholar
• Sáez-Valero, J., G. Sberna, C. A. McLean, C. L. Masters, and D. H. Small. 1997. Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease. Lancet 350:929.
   PubMedGoogle Scholar
• Sáez-Valero, J., G. Sberna, C. A. McLean, and D. H. Small. 1999. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease. J. Neurochem. 2:1600–1608.
   Google Scholar
• Sage, H. J., and R. W. Green. 1972. Common Lentil (Lens culinaris) Phytohemagglutinin. Methods Enzymol. 28:332–339.
   Google Scholar
• Santos, S. C., I. Vala, C. Miguel, J. T. Barata, P. Garção, and P. Agostinho. 2007. Expression and subcellular localization of a novel nuclear acetylcholinesterase protein. J. Biol. Chem. 282:25597–25603.
   PubMed Web of Science ®Google Scholar
• Sberna, G., J. Sáez-Valero, K. Beyreuther, C. L. Masters, and D. H. Small. 1997. The amyloid β-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J. Neurochem. 69:1177–1184.
   PubMed Web of Science ®Google Scholar
• Sberna, G., J. Sáez-Valero, Q. X. Li, C. Czech, K. Beyreuther, C. L. Masters, C. A. McLean, and D. H. Small. 1998. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease. J. Neurochem. 71:723–731.
   PubMed Web of Science ®Google Scholar
• Selkoe, D. J. 2004. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat. Cell Biol. 6:1054–1061.
   PubMed Web of Science ®Google Scholar
• Siman, R., and J. Velji. 2003. Localization of presenilin-nicastrin complexes and gamma-secretase activity to the trans-Golgi network. J. Neurochem. 84:1143–1153.
   PubMed Web of Science ®Google Scholar
• Sklan, E. H., A. Berson, K. R. Birikh, A. Gutnick, O. Shahar, S. Shoham, and H. Soreq. 2006. Acetylcholinesterase modulates stress-induced motor responses through catalytic and noncatalytic properties. Biol. Psychiatry 60:741–751.
   PubMedGoogle Scholar
• Sternfeld, M., S. Shoham, O. Klein, C. Flores-Flores, T. Evron, G. H. Idelson, D. Kitsberg, J. W. Patrick, and H. Soreq. 2000. Excess “read-through” acetylcholinesterase attenuates but the “synaptic” variant intensifies neurodeterioration correlates. Proc. Natl. Acad. Sci. USA 97:8647–8652.
   PubMed Web of Science ®Google Scholar
• St. George-Hyslop, P. H. 2000. Molecular genetics of Alzheimer's disease. Biol. Psychiatry 47:183–199.
   PubMed Web of Science ®Google Scholar
• Tandon, A., and P. Fraser. 2002. The presenilins. Genome Biol. 3:3014.
   Web of Science ®Google Scholar
• Thinakaran, G., D. R. Borchelt, M. K. Lee, H. H. Slunt, L. Spitzer, G. Kim, T. Ratovitsky, F. Davenport, C. Nordstedt, M. Seeger, J. Hardy, A. I. Levey, S. E. Gandy, N. A. Jenkins, N. G. Copeland, D. L. Price, and S. S. Sisodia. 1996. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17:181–190.
   PubMed Web of Science ®Google Scholar
• Ulrich, J., W. Meier-Ruge, A. Probst, E. Meier, and S. Ipsen. 1990. Senile plaques: staining for acetylcholinesterase and A4 protein: a comparative study in the hippocampus and entorhinal cortex. Acta Neuropathol. 80:624–628.
   PubMed Web of Science ®Google Scholar
• Wolfe, M. S. 2007. When loss is gain: reduced presenilin proteolytic function leads to increased Aβ42/Aβ40. EMBO J. 8:136–140.
   Google Scholar
• Wright, C. I., C. Guela, and M. M. Mesulam. 1993. Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:683–686.
   PubMed Web of Science ®Google Scholar
• Xie, W., J. A. Stribley, A. Chatonnet, P. J. Wilder, A. Rizzino, R. D. McComb, P. Taylor, S. H. Hinrichs, and O. Lockridge. 2000. Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J. Pharmacol. Exp. Ther. 293:896–902.
   PubMed Web of Science ®Google Scholar
• Zimmermann, M., F. Gardoni, E. Marcello, F. Colciaghi, B. Borroni, A. Padovani, F. Cattabeni, and M. Di Luca. 2004. Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines. J. Neurochem. 90:1489–1499.
   PubMed Web of Science ®Google Scholar